ENTRY       D03213                      Drug
NAME        Apixaban (JAN/USAN/INN);
            Eliquis (TN)
PRODUCT     ELIQUIS (A-S Medication Solutions)
            ELIQUIS (A-S Medication Solutions)
            ELIQUIS (Aphena Pharma Solutions - Tennessee)
            ELIQUIS (Bryant Ranch Prepack)
            ELIQUIS (Bryant Ranch Prepack)
            ELIQUIS (Cardinal Health 107)
            ELIQUIS (E.R. Squibb & Sons)
            ELIQUIS (Pharmasource Meds)
            ELIQUIS (REMEDYREPACK)
  GENERIC   APIXABAN (Indoco Remedies Limited)
FORMULA     C25H25N5O4
EXACT_MASS  459.1907
MOL_WEIGHT  459.4971
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01662  Factor Xa inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02925  CYP3A5 substrate
            Transporter substrate
             DG01665  ABCB1 substrate
             DG01913  ABCG2 substrate
REMARK      Therapeutic category: 3339
            ATC code: B01AF02
            Product: D03213<JP/US>
EFFICACY    Anticoagulant, Antithrombotic, Factor Xa inhibitor
  DISEASE   Deep vein thrombosis [DS:H01723]
TARGET      F10 [HSA:2159] [KO:K01314]
  PATHWAY   hsa04610(2159)  Complement and coagulation cascades
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]
            Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]
INTERACTION  
STR_MAP     map07049  Antithrombosis agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AF Direct factor Xa inhibitors
                 B01AF02 Apixaban
                  D03213  Apixaban (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Products and Modifiers
              Anticoagulants
               Factor Xa Inhibitors, Direct
                Apixaban
                 D03213  Apixaban (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              33  Blood and body fluid agents
               333  Anticoagulants
                3339  Others
                 D03213  Apixaban (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01662  Factor Xa inhibitor
                D03213  Apixaban
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D03213  Apixaban
              DG02925  CYP3A5 substrate
               D03213  Apixaban
             Transporter substrate
              DG01665  ABCB1 substrate
               D03213  Apixaban
              DG01913  ABCG2 substrate
               D03213  Apixaban
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Serine peptidases
                F10
                 D03213  Apixaban (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03213
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03213
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03213
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03213
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D03213
             Drug transporters
              D03213
DBLINKS     CAS: 503612-47-3
            PubChem: 17397366
            ChEBI: 72296
            PDB-CCD: GG2
            LigandBox: D03213
            NIKKAJI: J2.566.952E
ATOM        34
            1   C1x C    21.2579  -15.3879
            2   C1x C    21.2579  -16.7863
            3   C5x C    22.4689  -17.4855
            4   N1y N    23.6799  -16.7863
            5   C1x C    23.6799  -15.3879
            6   C1x C    22.4689  -14.6887
            7   C8y C    24.9097  -17.4965
            8   C8x C    24.9094  -18.8839
            9   C8x C    26.1203  -19.5833
            10  C8y C    27.3315  -18.8845
            11  C8x C    27.3318  -17.4971
            12  C8x C    26.1209  -16.7976
            13  N1y N    28.5492  -19.5878
            14  C1x C    28.5489  -20.9815
            15  C1x C    29.7597  -21.6809
            16  C8y C    30.9709  -20.9822
            17  C8y C    30.9714  -19.5886
            18  C5x C    29.7605  -18.8890
            19  O5x O    22.4689  -18.8838
            20  O5x O    29.7609  -17.4858
            21  C8y C    32.2962  -21.4131
            22  N5x N    33.1156  -20.2860
            23  N4y N    32.2968  -19.1583
            24  C8y C    32.7204  -17.8544
            25  C5a C    32.7279  -22.7430
            26  N1a N    34.1279  -22.7430
            27  O5a O    31.9130  -23.8647
            28  C8x C    34.1204  -17.8544
            29  C8x C    34.8204  -16.6420
            30  C8y C    34.1204  -15.4296
            31  C8x C    32.7204  -15.4296
            32  C8x C    32.0204  -16.6420
            33  O2a O    34.8256  -14.2088
            34  C1a C    36.2600  -14.2091
BOND        38
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12   11  12 2
            13    7  12 1
            14   10  13 1
            15   13  14 1
            16   14  15 1
            17   15  16 1
            18   16  17 2
            19   17  18 1
            20   13  18 1
            21    3  19 2
            22   18  20 2
            23   16  21 1
            24   21  22 2
            25   22  23 1
            26   17  23 1
            27   23  24 1
            28   21  25 1
            29   25  26 1
            30   25  27 2
            31   24  28 1
            32   28  29 2
            33   29  30 1
            34   30  31 2
            35   31  32 1
            36   24  32 2
            37   30  33 1
            38   33  34 1
///
